TWO SIGMA INVESTMENTS, LP - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 65 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 14.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$139,000
-70.7%
188,855
-62.8%
0.00%
-75.0%
Q1 2020$474,000
-63.8%
508,113
-20.8%
0.00%0.0%
Q4 2019$1,309,000
+110.1%
641,564
+195.3%
0.00%
+100.0%
Q3 2019$623,000
-85.4%
217,223
-61.1%
0.00%
-85.7%
Q2 2019$4,280,000
-11.2%
557,965
+53.9%
0.01%
-12.5%
Q1 2019$4,819,000
+92.1%
362,593
+125.1%
0.02%
+60.0%
Q4 2018$2,509,000
-50.5%
161,066
-8.8%
0.01%
-33.3%
Q2 2018$5,070,000
+42.6%
176,648
+4.3%
0.02%
+25.0%
Q1 2017$3,556,000
-46.2%
169,331
-51.9%
0.01%
-52.0%
Q4 2016$6,614,000
+34.8%
351,819
+49.8%
0.02%
+38.9%
Q3 2016$4,905,000
-52.9%
234,928
-42.5%
0.02%
-60.0%
Q2 2016$10,416,000
-21.9%
408,405
-19.0%
0.04%
-29.7%
Q1 2016$13,332,000
+59.1%
504,045
+157.3%
0.06%
+60.0%
Q4 2015$8,379,000
+79.7%
195,872
+39.8%
0.04%
+73.9%
Q1 2015$4,663,000
+592.9%
140,124
+751.2%
0.02%
+475.0%
Q4 2014$673,000
-73.0%
16,461
-77.6%
0.00%
-63.6%
Q3 2014$2,491,000
+18.3%
73,521
+17.7%
0.01%
+22.2%
Q2 2014$2,105,000
-27.3%
62,445
-18.3%
0.01%
-43.8%
Q1 2014$2,896,000
+132.4%
76,386
+79.0%
0.02%
+128.6%
Q4 2013$1,246,00042,6820.01%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,045,400$21,953,00012.28%
SCOPIA CAPITAL MANAGEMENT LP 5,568,306$116,934,0002.16%
GREAT POINT PARTNERS LLC 432,500$9,083,0001.80%
Consonance Capital Management LP 619,419$13,008,0001.36%
RA Capital Management 489,828$10,286,0001.26%
Ghost Tree Capital, LLC 300,000$6,300,0001.17%
DLD Asset Management, LP 281,900$5,920,0000.95%
DLD Asset Management, LP 281,900$5,914,0000.95%
Worth Venture Partners, LLC 36,650$770,0000.68%
Malaga Cove Capital, LLC 51,013$939,0000.57%
View complete list of ACORDA THERAPEUTICS INC shareholders